Second Sight Medical Products Inc. (EYES): closed at $0.88 on Tuesday, August 04


Second Sight Medical Products Inc. (NASDAQ:EYES) changes shares on Tuesday trading session, with a change of 1.81% or $0.02 shares. The trading starts at $0.9034 and closed at $0.88 throughout the day. The trading session low price was $0.8726 and day high was $0.9056 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.21 million while its average volume is 921.07K. In other hand, the EYES market cap reached to $20.92M.

On July 10, 2020, BRIEF-Second Sight Medical Products On July 7 Entered Into Lease With Sylmar Biomedical Park To Lease Smaller Portion Of Present Facility. According to the news reported on Reuters, * SECOND SIGHT MEDICAL PRODUCTS – ON JULY 7 ENTERED INTO LEASE WITH SYLMAR BIOMEDICAL PARK, LLC, TO LEASE SMALLER PORTION OF PRESENT FACILITY

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 0.07% and down -3.78% for month. Its quarterly performance was -16.67% below, while its half year performance is down -81.79%. EYES yearly performance stood at negative -85.59% and fall -84.84% for year-to-date. Current recommendation for Second Sight Medical Products Inc. is 2.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. EYES EPS (TTM) for 12-month is -2.10. EPS for this year is 46.00%, while for the next year its value is -1.40. Its EPS Q/Q reached 29.30%. It has an EPS of 27.30% up for past five years.

Let’s take a look on the analyst recommendations on EYES for the current month and previous month. For the current month, 1 of 1 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $10.00 – $10.00. Average target price for EYES was reached at $10.00.

The insider ownership moved to 0.10% and institutional holding shifted to 32.30%.

The company posted an EPS (TTM) of -2.10. According to the most recent quarter report on (Jun 2020), 1 analysts estimated an average EPS of -0.41, while -0.56 EPS posted a year ago period. Analyst Estimated EPS for EYES published in the report was -$0.41 – -$0.41 during the same period. Comparing with last year, the average estimated EPS was -0.56 which is higher than -0.57 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for EYES fall -74.62% for period of 200 days. SMA for 50 days was -9.86% which is showing red signal, while SMA-20 was 0.28%. The moving average value for Second Sight Medical Products Inc. (EYES) is 628.74k and 2.64% for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in EYES stock. On Feb 20, McGuire Jonathan Will, Chief Executive Officer, sold 1,793 trading shares at the cost of $5.44, which valued at 9754.0. On Aug 20, McGuire Jonathan Will, Chief Executive Officer, sold 3,902 shares at the cost of $0.81, with total shares of 142,770.